MESA LABORATORIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.5 USD | +2.26% |
|
+3.19% | +0.72% |
Chart calendar Mesa Laboratories, Inc.
0899fede9c6567e8a20d3e73d7318b.nR11sZBptcBiytcqH_E7YsWhJjF6u08iP_tsFmwTgXQ.72RM5ckP5pkM_ZRGJ5ZfB47VE3I84h5QesIeRxt78xfaVC3y3jjPrVGnlg~2c402ed41a1fabc7c190ca5aec719d23
Upcoming events on Mesa Laboratories, Inc.
Past events on Mesa Laboratories, Inc.
| 05/02/2024 06:30 pm | Q3 2024 Earnings Release |
| 06/11/2023 06:30 pm | Q2 2024 Earnings Release |
| 03/08/2023 05:30 pm | Q1 2024 Earnings Release |
| 25/05/2023 05:30 pm | Q4 2023 Earnings Release |
| 06/02/2023 07:06 pm | Q3 2023 Earnings Release |
| 03/11/2022 05:30 pm | Interim 2023 Earnings Release |
| 26/08/2022 08:30 pm | Annual General Meeting |
| 04/08/2022 05:30 pm | Q1 2023 Earnings Release |
| 31/05/2022 05:30 pm | FY 2022 Earnings Release |
| 03/02/2022 06:30 pm | Q3 2022 Earnings Release |
| 04/11/2021 05:30 pm | Interim 2022 Earnings Release |
| 27/08/2021 09:30 pm | Annual General Meeting |
| 05/08/2021 05:30 pm | Q1 2022 Earnings Release |
| 01/06/2021 05:30 pm | FY 2021 Earnings Release |
| 03/02/2021 06:30 pm | Q3 2021 Earnings Release |
| 05/11/2020 06:30 pm | Interim 2021 Earnings Release |
| 28/08/2020 | Annual General Meeting |
| 06/08/2020 05:30 pm | Q1 2021 Earnings Release |
| 01/06/2020 05:30 pm | FY 2020 Earnings Release |
| 10/02/2020 06:30 pm | Q3 2020 Earnings Release |
Past dividends on Mesa Laboratories, Inc.
| 28/02/2024 | Quarterly 0.16 USD |
| 29/11/2023 | Quarterly 0.16 USD |
| 30/08/2023 | Quarterly 0.16 USD |
| 30/05/2023 | Quarterly 0.16 USD |
| 27/02/2023 | Quarterly 0.16 USD |
| 29/11/2022 | Quarterly 0.16 USD |
| 30/08/2022 | Quarterly 0.16 USD |
| 27/05/2022 | Quarterly 0.16 USD |
| 25/02/2022 | Quarterly 0.16 USD |
| 29/11/2021 | Quarterly 0.16 USD |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 103 105 -2.05% | 118 118 -0.24% | 134 131 2.33% | 184 181 1.82% | 219 222 -1.25% | 212 |
|
EBITDA Million USD | Released Forecast Spread | 24,0 32,2 -25.52% | 31,1 31,6 -1.37% | 39,3 37,3 5.21% | 41,2 45,1 -8.73% | 49,7 53,1 -6.5% | 49,3 |
|
EBIT Million USD | Released Forecast Spread | 14,6 16,8 -13.42% | 18,1 20,9 -13.33% | 12,4 24,5 -49.6% | 37,9 43,5 -12.88% | 45,8 49,2 -6.88% | 44,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8,62 12,5 -31.02% | 3,43 0,00 - | 2,30 9,83 -76.58% | 3,57 6,90 -48.2% | -0,39 2,45 -115.88% | -1,00 |
|
Net income Million USD | Released Forecast Spread | 7,48 10,5 -28.71% | 1,35 6,03 -77.64% | 3,27 0,19 1590.42% | 1,87 6,24 -70.02% | 0,93 2,34 -60.25% | -0,30 |
|
EPS USD | Released Forecast Spread | 1,86 2,59 -28.19% | 0,31 1,45 -78.62% | 0,64 0,12 456.23% | 0,35 1,18 -70.26% | 0,17 0,43 -60.44% | -0,06 |
| Announcement Date | 03/06/19 | 01/06/20 | 01/06/21 | 31/05/22 | 25/05/23 | - |
Quarterly results
| Fiscal Period | March | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 54,7 44,5 23% | 58,9 56,3 4.58% | 50,5 52,2 -3.3% | 58,7 53,5 9.86% | 54,3 57,1 -4.84% | 55,6 58,1 -4.24% | 50,6 51,6 -1.79% | 53,2 54,7 -2.72% | 53,5 54,6 -2.06% | 55,3 | 57,2 | 61,5 | 59,0 | 56,0 |
|
EBITDA Million USD | Released Forecast Spread | 8,03 11,0 -27.02% | 12,7 13,4 -4.69% | 6,97 13,7 -49.11% | 16,4 10,6 55.65% | 14,0 14,0 0.63% | 12,3 16,1 -23.67% | 10,4 11,0 -5.11% | 11,2 10,7 4.85% | 12,0 11,7 2.35% | 13,7 | ||||
|
EBIT Million USD | Released Forecast Spread | 13,8 10,7 28.79% | 11,7 12,7 -8% | 6,16 11,6 -46.91% | 15,5 9,53 62.29% | 12,9 12,6 2.03% | 10,7 13,7 -21.81% | 9,52 10,8 -11.4% | 10,3 11,3 -8.78% | 10,9 11,1 -1.79% | 12,5 | 13,0 | 13,1 | 13,0 | 13,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,34 3,00 -178.03% | -0,05 3,30 -101.39% | -5,41 -0,40 -1253% | 3,38 -2,50 235.36% | 1,92 0,20 858% | -0,28 1,55 -117.87% | -0,94 -0,10 -837% | -1,33 1,55 -185.48% | 1,95 0,20 873% | -0,70 | 0,00 | 0,20 | 0,30 | 0,50 |
|
Net income Million USD | Released Forecast Spread | -2,06 2,25 -191.56% | -1,78 2,45 -172.82% | -1,44 -0,25 -475.2% | 1,31 -1,95 166.97% | 0,45 0,15 200.67% | 0,61 1,25 -51.12% | -0,55 -0,10 -449% | -1,23 0,85 -244.71% | 2,12 0,20 958% | -0,65 | 0,00 | 0,10 | 0,30 | 0,30 |
|
EPS USD | Released Forecast Spread | -0,39 0,42 -192.74% | -0,34 0,48 -170.83% | -0,27 0,00 -8444.3% | 0,24 -0,31 177.51% | 0,08 0,14 -43.94% | 0,11 0,37 -70.1% | -0,10 -0,02 -400% | -0,23 0,16 -248.39% | 0,39 0,04 875% | -0,12 | 0,00 | 0,03 | 0,05 | 0,06 |
| Announcement Date | 03/02/22 | 31/05/22 | 04/08/22 | 03/11/22 | 06/02/23 | 25/05/23 | 03/08/23 | 06/11/23 | 05/02/24 | - | - | - | - | - |
| Today 01:35 am | SILK ROAD MEDICAL, INC: Q1 2024 Earnings Release |
| Today 01:35 am | MERIT MEDICAL SYSTEMS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | REPLIGEN CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | BAUSCH + LOMB CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | PROCEPT BIOROBOTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 03:30 pm | LIVANOVA PLC: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | CENCORA, INC.: Q2 2024 Earnings Release |
| 02/05/2024 01:31 am | ATRICURE, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:40 am | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
Past sector events for Mesa Laboratories, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MLAB Stock
- Calendar Mesa Laboratories, Inc.
